Предыдущая страница реферата | 1  2  3  4 | Следующая страница реферата

11. Щепотин И.Б., Эванс С.Р. Рак желудка: практическое руководство по профилактике, диагностике и лечению. Киев «Книга Плюс» 2000.–227с.

12. Гарин А.М., Базин И.С., Нариманов М.Н. Обзор возможностей химиотерапии рака желудка. Русский мед. журнал, т. 9, №22, 2001, с. 989–991.

13. Rothenberg M.L. Иринотекан (СРТ–11): новые данные и перспективы применения – колоректальный рак и другие злокачественные опухоли. The Oncologist, 2001:6;66–80.

14. Ridwelski K., Gebauer T., Fahlke J., et al. Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer. Ann. Oncol., 2001, v. 12, p. 47–51.

15. Van Custem E.J.D., Ajani J., Tjulandin S., et al. Docetaxel in combination with cisplatinum with or without 5–fluorouracil in patients with advanced gastric or GE junction adenocarcinoma: preliminary results. ESMO, 2000, Hamburg, ab. 276.

16. Roth A.D., Maibach R., Marinelli G., et al. Taxotere–cisplatin in advanced gastric carcinoma: an active drug combination. Proc. ASCO, 1998, ab. 1088.

17. Aiko Takashi and Mitsuru Sasako for The General Rules’ Committee of the Japanese Gastric Cancer Association. The new Japanese Classification of Gastric Carcinoma: Points to be revised. Gastric Cancer (1998) No. 1: 25–30

18. Baldus SE, Zirbes TK, Monig SP et al. Histopathological subtypes and prognosis of gastric cancer are correlated with the expression of mucin–associated sialylated antigens: Sialosyl–Lewis(a), Sialosyl–Lewis–Tn. Tumor Biol; 19(6): 445–53, 1998.

19. Bonenkamp J. J., J. Hermans, M. Sasako, and C. J. H. van de Velde. Quality Control of Lymph Node Dissection in the Dutch Randomized Trial of D1 and D2 Lymph Node Dissection for Gastric Cancer. Gastric Cancer (1998), No. 1: 152–159

20. Daly John M., Thomas P. J. Hennessy, John V. Reynolds. M.Sasako. Surgical Management of the Gastric Cancer: The Japanese Experience. Management of Upper Gastrointestinal Cancer. P.106–122.

21. Egashira Yutaro, Tadakazu Shimoda, and Masahiro Ikegami. Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathology International, 1999; 49: 55–61.

22. Gotoda T., M. Sasako, H. Ono, H. Katai, T. Sano, and T. Shimoda. Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer. British Journal of Surgery, 2001, 88, pp. 444–449.

23. Gotoda Takuji, Akio Yanagisawa, Mitsuru Sasako, Hiroyuki Ono, Yukihiro Nakanishi, Tadakazu Shimoda, and Yo Kato. Incidence in lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer, 2000, 3: 219–225.

24. Hunstman G David, Fatima Carneiro, Frank R.Lewis et al. Early gastric cancer in young, asymptomatic carriers of germ–line E–cadherin mutations. The New England Jornal of Medicine. N25, Vol. 344:1904–1909, 2001.

25. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma – 2nd English Edition. Gastric Cancer (1998), No. 1: 10–24

26. Johnson C.D., I. Taylor. Recent Advances in Surgery. Mitsuru Sasako. Surgery for gastric cancer. No. 23 Surgery for Gastric Cancer. 2000.p.11–21.

27. Klimenkov A.A., Nikulin M.P., Tupitsyn N.N. et al. Immunophenotype of stomach cancer and some immunological factors of prognosis. International Journal of Cancer. 18th UICC International Cancer Congress, 30 June –5 July, 2002, Oslo – Norway, Abstract book, p.152.

28. McCulloch J. Peter and Mitsuru Sasako. Tumour biology, investigation and surgical management. Management of Gastrointestinal Cancer. 1996, p.157–180.

29. Nakagoe Tohru, Fukushima Kiyoyasu, Terumitsu Sawai et al. Increased expression of sialyl Lewisx antigen as a prognostic factor in patients with stage 0, I, and II gastric cancer. Cancer Letters 175 (2002) 213–221

30. Nakamori Shoji, Hiroshi Furukawa, Masahiro Hiratsuka et al. Expression of Carbohydrate Antigen Sialyl Lea: A New Functional Prognostic Factor in Gastric Cancer.J.Clin.Oncology, Vol.15, N2, 1997, 816–825.

31. Ono H., H. Kondo, T. Gotoda, K. Shirao, H. Yamaguchi, D. Saito, K. Hosokawa, T. Shimoda, S. Yoshida. Endoscopic mucosal resection for treatment of early gastric cancer. Gut, February 2001, Vol. 48, No, 2, pp. 225–229.

32. Rembacken B. G., T. Gotoda, T. Fujii, A. T. R. Axon. Endoscopic mucosal resection. Review. Endoscopy. 2001, 33 (8) pp. 709–718.

33. Roder J. D., J. J. Bonenkamp, J. Craven, C. J. H. van de Velde, M. Sasako, K. Bottcher, H. J. Stein. Lymphadenectomy for gastric cancer in clinical trials: update. World J. Surgery. 19,pp. 546–553, 1995.

34. Sasako M. for the Dutch Gastric Cancer Study Group. Risk factors for surgical treatment in the Dutch gastric cancer trial. British Journal of Surgery. 1997, 84, pp.1567–1571

35. Sasako Mitsuru, Hitoshi Katai, Takeshi Sano, Keiichi Maruyama. Management of complications after gastectomy with extent lymphadenectomy. Surgical Oncology, 9 (2000), pp.31–34.

Рекомендуем скачать другие рефераты по теме: смс сообщения, bestreferat ru.





Предыдущая страница реферата | 1  2  3  4 | Следующая страница реферата